New-Onset Diabetes Mellitus in Patients with Idiopathic Membranous Nephropathy Undergoing Tacrolimus and Low-Dose Corticosteroid Therapy

New-Onset Diabetes Mellitus in Patients with Idiopathic Membranous Nephropathy Undergoing Tacrolimus and Low-Dose Corticosteroid Therapy

Background: Idiopathic membranous nephropathy (IMN) is the most common cause of nephrotic syndrome in adults. Although various studies have demonstrated the efficacy of tacrolimus combined with corticosteroids for treating IMN, both tacrolimus and corticosteroids have been shown to be diabetogenic,...

Full description

Bibliographic Details
Main Authors: Lina Shao, Juan Jin, Binxian Ye, Baihui Xu, Yiwen Li, Jianguang Gong, Jiong Zhang, Maosheng Chen, Qiang He
Format: Article
Language:English
Published: Karger Publishers 2019-10-01
Series:Kidney & Blood Pressure Research
Subjects:
new-onset diabetes mellitus
idiopathic membranous nephropathy
tacrolimus
corticosteroid
age
Online Access:https://www.karger.com/Article/FullText/502693

Similar Items

Similar Items